IMC Chicago’s ClearPoint Neuro CLPT Stock Holding History

IMC Chicago’s Portfolio CLPT Stock Details CLPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2M	Buy	112,000 +52,100	+87%	+$651K	﹤0.01%	3038
2026 Q1	$545K	Buy	59,900 +27,100	+83%	+$342K	﹤0.01%	3952
2025 Q4	$449K	Buy	+32,800	New	+$608K	﹤0.01%	3555

Other funds holding CLPT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Compass Financial Management Tampa, Florida $926M AUM

IMC Chicago's CLPT Position: Q2 2026 in Review

IMC Chicago reduced its ClearPoint Neuro (CLPT) stake by 44% in Q2 2026, selling an estimated $263K and leaving 26,494 shares worth $473K. The position accounts for ﹤0.01% of the portfolio, ranked #4713.

IMC Chicago first reported a position in CLPT in Q1 2026 and has held it in 2 quarters since. 129 funds tracked by Wall St. Rank hold CLPT as of Q2 2026.

IMC Chicago held 26,494 shares of ClearPoint Neuro worth $473K as of Q2 2026.
IMC Chicago sold 21,049 ClearPoint Neuro shares in Q2 2026, an estimated $263K.
ClearPoint Neuro made up ﹤0.01% of IMC Chicago's portfolio in Q2 2026, its #4713 holding.
IMC Chicago first reported a position in ClearPoint Neuro in Q1 2026 and has held it in 2 quarters since.
129 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.